ATE526945T1 - Verfahren zur erhöhung von fibronectin - Google Patents
Verfahren zur erhöhung von fibronectinInfo
- Publication number
- ATE526945T1 ATE526945T1 AT03789843T AT03789843T ATE526945T1 AT E526945 T1 ATE526945 T1 AT E526945T1 AT 03789843 T AT03789843 T AT 03789843T AT 03789843 T AT03789843 T AT 03789843T AT E526945 T1 ATE526945 T1 AT E526945T1
- Authority
- AT
- Austria
- Prior art keywords
- peptides
- compositions
- development
- fibronectin
- increase
- Prior art date
Links
- 102000016359 Fibronectins Human genes 0.000 title abstract 2
- 108010067306 Fibronectins Proteins 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 206010052428 Wound Diseases 0.000 abstract 2
- 208000027418 Wounds and injury Diseases 0.000 abstract 2
- 230000018109 developmental process Effects 0.000 abstract 2
- 230000035876 healing Effects 0.000 abstract 2
- 230000036074 healthy skin Effects 0.000 abstract 2
- 239000006071 cream Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 230000037390 scarring Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000037303 wrinkles Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/335,207 US7148194B2 (en) | 2002-12-30 | 2002-12-30 | Method to increase fibronectin |
| PCT/US2003/037053 WO2004060908A2 (en) | 2002-12-30 | 2003-11-18 | Method to increase fibronectin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE526945T1 true ATE526945T1 (de) | 2011-10-15 |
Family
ID=32655292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03789843T ATE526945T1 (de) | 2002-12-30 | 2003-11-18 | Verfahren zur erhöhung von fibronectin |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7148194B2 (de) |
| EP (1) | EP1578780B1 (de) |
| KR (1) | KR20050092026A (de) |
| CN (1) | CN1756839A (de) |
| AT (1) | ATE526945T1 (de) |
| AU (1) | AU2003294360B2 (de) |
| CA (1) | CA2511557A1 (de) |
| MX (1) | MXPA05007227A (de) |
| WO (1) | WO2004060908A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7189700B2 (en) * | 2003-06-20 | 2007-03-13 | Kimberly-Clark Worldwide, Inc. | Anti-chrondrosarcoma compounds |
| US20060068364A1 (en) * | 2004-09-29 | 2006-03-30 | Struck James T | Methods and devices for the prevention and treatment of gingival recession |
| CA2586035A1 (en) | 2004-11-01 | 2006-05-11 | Biosante Pharmaceuticals, Inc. | Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use |
| US7645583B2 (en) * | 2005-12-14 | 2010-01-12 | Kimberly-Clark Worldwide, Inc. | Identification of compounds for inhibiting complexation of C-reactive protein with fibronectin |
| TWI415628B (zh) * | 2006-02-28 | 2013-11-21 | Avon Prod Inc | 包含具有非天然胺基酸之胜肽之組合物及其使用方法 |
| US7879798B1 (en) | 2007-08-24 | 2011-02-01 | Regenicel, Inc. | Composition for indolent wound healing and methods of use therefor |
| CN104911168B (zh) * | 2015-06-30 | 2018-03-30 | 中国人民解放军第三军医大学第一附属医院 | I型胶原蛋白高亲和力多肽及其应用 |
| SG11201808528VA (en) | 2016-03-30 | 2018-10-30 | Convatec Technologies Inc | Modified wound dressings |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2507379A1 (fr) | 1981-06-05 | 1982-12-10 | Europ Composants Electron | Bloc de condensateurs en serie et multiplicateur de tension utilisant un tel bloc de condensateurs |
| US5270447A (en) | 1988-05-20 | 1993-12-14 | The United States Of America As Represented By The Department Of Health & Human Services | Metalloproteinase peptides: role in diagnosis and therapy |
| US5280106A (en) | 1988-05-20 | 1994-01-18 | Liotta Lance A | Matrix metalloproteinase peptides: role in diagnosis and therapy |
| US5698671A (en) | 1989-03-21 | 1997-12-16 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Metalloproteinase peptides |
| WO1991011714A1 (en) | 1990-01-26 | 1991-08-08 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | A method for quantitatively measuring collagenase |
| EP1262493A1 (de) | 1992-10-29 | 2002-12-04 | Bayer Corporation | Diagnostischer Test spezifisch für die latente Matrix Metalloproteinase no. 9 |
| JP3098640B2 (ja) | 1992-12-24 | 2000-10-16 | 富士薬品工業株式会社 | ヒト72−kDaゼラチナーゼ/IV型コラゲナーゼの免疫学的定量法 |
| JP2673929B2 (ja) | 1993-04-12 | 1997-11-05 | 富士薬品工業株式会社 | ヒト間質型コラゲナーゼと阻害剤との複合体の免疫学的定量法および臨床診断への応用 |
| US6150152A (en) | 1993-05-28 | 2000-11-21 | Washington University | Human macrophage metalloelastase |
| AU7128494A (en) | 1993-07-09 | 1995-02-06 | Celltech Limited | Gelatinase antagonists used for treating cancer |
| DK0714897T3 (da) | 1993-08-18 | 2001-03-19 | Banyu Pharma Co Ltd | Ring-kondenseret heteroaromatisk cyclopentenderivat med endothelinantagonist-aktivitet |
| JPH07303482A (ja) | 1993-11-30 | 1995-11-21 | Fuji Yakuhin Kogyo Kk | 新規なメタロプロテアーゼおよびそれをコードするdna |
| JPH07159402A (ja) | 1993-12-09 | 1995-06-23 | Kyodo Nyugyo Kk | Iv型コラゲナ−ゼ測定法 |
| JPH07330795A (ja) | 1994-06-07 | 1995-12-19 | Toagosei Co Ltd | ペプチドおよびモノクローナル抗体 |
| ATE226642T1 (de) | 1994-07-07 | 2002-11-15 | Tno | Modifizierte proenzyme als substrate für proteolische enzyme |
| DE19524720A1 (de) | 1995-07-12 | 1997-01-16 | Hoechst Ag | Zellspezifische Gentherapie mit Hilfe eines neuen Promotors für den "Tissue Inhibitor of Metalloproteinasn-3" |
| JPH08136548A (ja) | 1994-11-11 | 1996-05-31 | Morinaga & Co Ltd | 泌尿器癌の診断法 |
| JPH08134098A (ja) | 1994-11-11 | 1996-05-28 | Morinaga & Co Ltd | ヒトtimp−1の高感度測定法 |
| ATE354638T1 (de) | 1994-12-13 | 2007-03-15 | Human Genome Sciences Inc | Menschlicher gewebsinhibitor von metalloproteinase-4 |
| JP2949467B2 (ja) | 1995-02-16 | 1999-09-13 | 富士薬品工業株式会社 | 免疫学的測定法によるヒトプロマトリックスメタロプロテアーゼ7の定量 |
| US5770691A (en) | 1995-06-05 | 1998-06-23 | Regents Of The University Of Minnesota | Discriminatory substrates for MMP hydrolysis |
| JPH0987299A (ja) | 1995-07-14 | 1997-03-31 | Fuji Yakuhin Kogyo Kk | Mmp−2活性化因子に特異的なモノクローナル抗体 |
| WO1997004080A1 (en) | 1995-07-14 | 1997-02-06 | Fuji Yakuhin Kogyo Kabushiki Kaisha | Novel protein and monoclonal antibody specific thereto |
| JPH0984589A (ja) | 1995-07-14 | 1997-03-31 | Fuji Yakuhin Kogyo Kk | 新規なタンパク質 |
| IT1277904B1 (it) | 1995-08-07 | 1997-11-12 | Polifarma Spa | Metodo per determinare l'attivita' terapeutica di composti inibitori di metalloproteinasi, nuovi composti inibitori, e loro impiego |
| WO1997025437A1 (en) | 1996-01-04 | 1997-07-17 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method for assaying proteolytic enzymes using fluorescence-quenched substrates |
| JPH09206099A (ja) | 1996-01-31 | 1997-08-12 | Sekisui Chem Co Ltd | 細胞機能測定方法 |
| GB9615976D0 (en) | 1996-07-30 | 1996-09-11 | Center For Clinical & Basic Re | The use of proteinase inhibitors for the prevention or reduction of bone resorption |
| US6022948A (en) | 1996-09-17 | 2000-02-08 | Washington University | Method of cell surface activation and inhibition |
| US20020099004A1 (en) | 1996-12-06 | 2002-07-25 | Lund Leif Roge | Inhibition of invasive remodelling |
| AU6241698A (en) | 1997-01-21 | 1998-08-07 | Human Genome Sciences, Inc. | Tace-like and matrilysin-like polypeptides |
| JPH10210982A (ja) | 1997-01-31 | 1998-08-11 | Fuji Yakuhin Kogyo Kk | 新規なタンパク質 |
| US6017540A (en) | 1997-02-07 | 2000-01-25 | Fordham University | Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes |
| EP0972071A4 (de) | 1997-03-07 | 2004-04-21 | Tropix Inc | Versuchsanordnung für proteaseinhibitoren |
| WO1998040475A1 (en) | 1997-03-11 | 1998-09-17 | Abbott Laboratories | Human matrix metalloprotease gene, proteins encoded therefrom and methods of using same |
| AUPO573697A0 (en) | 1997-03-20 | 1997-04-10 | Prince Henry's Institute Of Medical Research | Diagnosis of endometrial cancer |
| JPH10287700A (ja) | 1997-04-10 | 1998-10-27 | Fuji Yakuhin Kogyo Kk | 活性型マトリライシン(mmp−7)に対する抗体及びそれを用いた免疫学的測定法 |
| JPH10313896A (ja) | 1997-05-15 | 1998-12-02 | Yamanouchi Pharmaceut Co Ltd | マトリックスメタロプロテアーゼに対する発色団又は蛍光団を有する新規な活性測定用合成基質 |
| US6043087A (en) | 1997-07-25 | 2000-03-28 | The New York Blood Center | Monospecific antibody reactive with matrix metalloproteinase cleavage products of fibrin(ogen) |
| DE69837516T2 (de) | 1997-11-14 | 2007-12-27 | Murata Mfg. Co., Ltd., Nagaokakyo | Vielschichtkondensator |
| EP1040196A2 (de) | 1997-12-19 | 2000-10-04 | American Home Products Corporation | Transgenes tiermodel für degenerative erkrankungen des knorpels |
| AU3980499A (en) | 1998-05-11 | 1999-11-29 | Endowment for Research in Human Biology, Inc., The | Use of neomycin for treating angiogenesis-related diseases |
| WO1999065519A1 (en) | 1998-06-16 | 1999-12-23 | The General Hospital Corporation | Matrix metalloproteinase proenzyme activator |
| US6191225B1 (en) | 1998-08-31 | 2001-02-20 | Ppg Industries Ohio, Inc. | Thermosetting compositions containing carboxylic acid functional polymers and epoxy functional polymers prepared by atom transfer radical polymerization |
| WO2000020860A1 (en) | 1998-10-08 | 2000-04-13 | Calbiochem Novabiochem Corporation | Diagnostic assay for matrix metalloproteinase 9 and use thereof |
| JP4439120B2 (ja) | 1998-10-16 | 2010-03-24 | 大塚製薬株式会社 | 新生血管特異的ペプチド |
| USH1973H1 (en) * | 1998-10-22 | 2001-07-03 | Novartis Ag | Human neutrophil collagenase splice variant |
| WO2000053219A2 (en) | 1999-03-11 | 2000-09-14 | Entremed, Inc. | Compositions and methods for treating cancer and hyperproliferative disorders |
| JP2000270874A (ja) | 1999-03-25 | 2000-10-03 | Fuji Chemical Industries Ltd | 新規な膜結合型メタロプロテアーゼ |
| US6274717B1 (en) | 1999-04-20 | 2001-08-14 | Smithkline Beecham Corporation | Splicing variant of human membrane-type matrix metalloproteinease-5 (MT-MMP5-L) |
| CA2377385A1 (en) | 1999-06-03 | 2000-12-14 | Jessie L.S. Au | Methods and compositions for modulating cell proliferation and cell death |
| JP2001072589A (ja) | 1999-07-06 | 2001-03-21 | Toagosei Co Ltd | 制癌剤 |
| US6403637B1 (en) | 1999-08-09 | 2002-06-11 | Univ Saint Louis | Methods of modulating matrix metalloproteinase activity and uses thereof |
| CA2383562A1 (en) | 1999-08-26 | 2001-03-01 | Keith M. Skubitz | Peptides capable of modulating the function of cd66 (ceacam) family members |
| GB9927576D0 (en) | 1999-11-23 | 2000-01-19 | Univ Birmingham | Novel assay |
| US20020063763A1 (en) | 2000-11-29 | 2002-05-30 | Mantell David Allen | Apparatus and method for removing air bubbles from an ink jet printhead |
| US7740841B1 (en) | 2000-01-28 | 2010-06-22 | Sunnybrook Health Science Center | Therapeutic method for reducing angiogenesis |
| AU2001249064A1 (en) | 2000-02-22 | 2001-09-03 | Mount Sinai School Of Medicine Of New York University | N-cadherin modulated migration, invasion, and metastasis |
| GB0004531D0 (en) | 2000-02-25 | 2000-04-19 | Richards Andrew J M | The treatment of respiratory diseases |
| US6812339B1 (en) | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
| US7094754B2 (en) | 2001-08-16 | 2006-08-22 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
| US7071164B2 (en) | 2001-08-16 | 2006-07-04 | Kimberly-Clark Worldwide, Inc. | Anti-cancer and wound healing compounds |
| US6906036B2 (en) * | 2001-08-16 | 2005-06-14 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
| US7189700B2 (en) | 2003-06-20 | 2007-03-13 | Kimberly-Clark Worldwide, Inc. | Anti-chrondrosarcoma compounds |
-
2002
- 2002-12-30 US US10/335,207 patent/US7148194B2/en not_active Expired - Lifetime
-
2003
- 2003-11-18 KR KR1020057012304A patent/KR20050092026A/ko not_active Abandoned
- 2003-11-18 AT AT03789843T patent/ATE526945T1/de not_active IP Right Cessation
- 2003-11-18 CN CNA2003801100365A patent/CN1756839A/zh active Pending
- 2003-11-18 EP EP03789843A patent/EP1578780B1/de not_active Expired - Lifetime
- 2003-11-18 WO PCT/US2003/037053 patent/WO2004060908A2/en not_active Ceased
- 2003-11-18 CA CA002511557A patent/CA2511557A1/en not_active Abandoned
- 2003-11-18 AU AU2003294360A patent/AU2003294360B2/en not_active Ceased
- 2003-11-18 MX MXPA05007227A patent/MXPA05007227A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003294360A1 (en) | 2004-07-29 |
| CN1756839A (zh) | 2006-04-05 |
| EP1578780B1 (de) | 2011-10-05 |
| KR20050092026A (ko) | 2005-09-16 |
| CA2511557A1 (en) | 2004-07-22 |
| MXPA05007227A (es) | 2005-09-12 |
| EP1578780A2 (de) | 2005-09-28 |
| WO2004060908A3 (en) | 2005-08-04 |
| AU2003294360B2 (en) | 2010-02-25 |
| US20040127421A1 (en) | 2004-07-01 |
| EP1578780A4 (de) | 2008-05-14 |
| US7148194B2 (en) | 2006-12-12 |
| WO2004060908A2 (en) | 2004-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA04001034A (es) | Compuestos para sanar heridas y en contra de envejecimiento. | |
| ATE429922T1 (de) | Topische gel-abgabesysteme zur behandlung von hauterkrankungen | |
| DE60142590D1 (de) | Verwendung von Botulinum Toxin zur Behandlung von post-operative Schmerzen | |
| ATE550005T1 (de) | Integriertes wundverbandsystem | |
| ATE415962T1 (de) | Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs | |
| SI2298338T1 (sl) | Laktoferinski sestavki in postopki za zdravljenjekožnih ran | |
| DE60114580D1 (de) | Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen | |
| ATE395928T1 (de) | Expressionsvektoren und zellinien zur expression von vaskulärem wachstumsfaktor d, sowie verfahren zur behandlung von melanomen | |
| DE10085007T1 (de) | Antiinfektionszusammensetzungen zur Behandlung von erkranktem Gewebe, wie Lippenherpes | |
| ATE551976T1 (de) | Verfahren zur herstellung eines festen verbands zur behandlung von verletztem gewebe | |
| DE60023816D1 (de) | Verwendung von Lycopin in Zusammensetzungen zur Behandlung von Hautalterungs-Erscheinungen | |
| WO2005079822A3 (en) | Pharmaceutical composition comprising a fibrin matrix and dermal fibroblasts for the treatment of wounds | |
| EP1430933A3 (de) | Kosmetische und pharmazeutische Zusammensetzungen enthaltend Steroidsulfatase-Inhibitoren und deren Verwendung zur Verminderung von Haarausfall | |
| DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
| ATE332705T1 (de) | Verwendung von in der mittlere oder späte follikuläre phase verabreichte lh zur behandlung von anovulatorischen frauen | |
| DE59707519D1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen | |
| EP1578780A4 (de) | Verfahren zur erhöhung von fibronectin | |
| ES2113222T3 (es) | Utilizacion de derivados de acido benzoico para estimular el proceso de renovacion epidermica y tratar la piel. | |
| TWI348912B (en) | Method and composition for treating skin wounds with epidermal growth factor | |
| ATE255426T1 (de) | Dermales hüllgewebe in der wundheilung | |
| ATE337005T1 (de) | Nagellack enthaltend tazaroten und verwendung dessen zur behandlung und/oder zur prävention von psoriasis | |
| DE69822276D1 (de) | Kräuter formulierung mit therapeutischer und kosmetischer verwendung zur behandlung von allgemeinen hauterkrankungen | |
| DE69932922D1 (de) | Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen | |
| DE69920015D1 (de) | Verfahren zur induktion der herstellung von wachstumsfaktoren | |
| DE60036725D1 (de) | Zusammensetzungen enthaltend vernix und ein uv-schutzmittel, und deren verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |